Recent 8-K filings for IVPR

• March 2, 2026, 6:59 PM ET leadership materiality 0.30 neutral item 5.02

  Director Erinn Thomas-Mackey resigns from Inspire Veterinary board

  Erinn Thomas-Mackey resigned from the Board effective February 26, 2026.

• January 21, 2026, 6:59 PM ET other material materiality 0.85 negative item 3.01item 8.01 ◈ Listing & Compliance Notices

  Inspire Veterinary Partners delisted from Nasdaq, now trades on OTCQB under IVPR

  Nasdaq denied Company's request to continue listing; common stock suspended from Nasdaq on Jan 21, 2026.

• January 20, 2026, 6:59 PM ET debt materiality 0.40 negative item 1.01item 3.02item 9.01 ◈ Equity Issuances◈ Material Agreements

  Inspire cancels $25K debt by issuing 2.5M shares to Target Capital 1 LLC

  Entered Cancellation and Exchange Agreement on Jan 14, 2026 with Target Capital 1 LLC.

• January 13, 2026, 6:59 PM ET other material materiality 0.50 neutral item 5.03

  Inspire Veterinary increases authorized Class A common shares from 100M to 700M

  Authorized Class A common shares increased from 100,000,000 to 700,000,000, effective January 9, 2026.

• January 12, 2026, 6:59 PM ET debt materiality 0.65 negative item 1.01item 2.03item 3.02item 9.01 ◈ Debt Financings ×2◈ Equity Issuances ×2◈ Material Agreements

  Inspire Veterinary issues $975K convertible note at 23% OID, 10% interest; director resigns

  Issued $975K principal secured convertible note to Manetto Hill Fund for $750K; 10% interest, matures Dec 31, 2026.

• December 30, 2025, 6:59 PM ET debt materiality 0.55 neutral item 1.01item 3.02 ◈ Equity Issuances

  Inspire Veterinary cancels $150K debt in exchange for 3M common shares at $0.05 each

  Cancelled $150,000 of outstanding principal under June 2025 promissory note with Target Capital 1 LLC.

• December 17, 2025, 6:59 PM ET other material materiality 0.50 neutral item 1.01 ◈ Material Agreements

  Inspire Veterinary issues 9.45M shares to 622 Capital for business development consulting

  9,450,000 shares of Class A common stock issued as compensation for business development consulting services.

• December 11, 2025, 6:59 PM ET other materiality 0.10 neutral item 5.07

  Inspire Veterinary holds annual meeting; all director nominees elected, auditor ratified

  Kimball Carr, Larry Alexander, Phillip Balatsos, Charles Stith Keiser, Anne Murphy, Erin Thomas-Mackey, Timothy Watters elected as directors.

• December 5, 2025, 6:59 PM ET other material materiality 0.70 negative item 1.01

  Inspire Veterinary lowers Series B floor price to $0.05, redeems 2,027 shares for $2.7M

  Floor price reduced from $0.1879 to $0.05 per share for Series B Preferred Stock.

• November 24, 2025, 6:59 PM ET regulatory materiality 0.65 negative item 3.01

  Inspire Veterinary Partners gets Nasdaq hearing date for delisting appeal on Jan 13, 2026

  Previously reported non-compliance with Nasdaq minimum bid price rule (bid <$1 for 30 consecutive days).

• November 17, 2025, 6:59 PM ET regulatory materiality 0.90 negative item 3.01 ◈ Listing & Compliance Notices

  Inspire Veterinary Partners receives Nasdaq delisting notice; suspension set for Nov 24, 2025

  Received delisting notice from Nasdaq on Nov 13, 2025 for failing minimum bid price requirement.

• November 10, 2025, 6:59 PM ET debt materiality 0.60 negative item 1.01item 2.03item 3.02 ◈ Debt Financings◈ Equity Issuances

  Inspire Veterinary issues $357k convertible notes at 30% OID to two investors

  Issued two Senior Convertible Promissory Notes, each $178,571 principal, to Keystone Capital Partners and Seven Knots at 30% OID, netting $250k.

• October 21, 2025, 7:59 PM ET other material materiality 0.65 negative item 4.01 ◈ Auditor Changes ×2

  Inspire Veterinary dismisses auditor Kreit & Chiu; going concern, material weaknesses cited

  Dismissed Kreit & Chiu CPA LLP as independent auditor on October 16, 2025; no disagreements occurred.

• September 15, 2025, 7:59 PM ET other material materiality 0.65 neutral item 1.01item 3.02item 9.01 ◈ Equity Issuances ×2

  Inspire Veterinary Partners sells 1,253 Series B preferred shares for $1.0M gross proceeds

  Amended July 28 SPA to add new institutional investors, including KCP Fund I, LLC.

• September 2, 2025, 7:59 PM ET regulatory materiality 0.55 positive item 8.01item 9.01

  Inspire Veterinary regains Nasdaq compliance with $2.5M equity rule

  Received formal Nasdaq notification on Aug 26, 2025 confirming compliance with Listing Rule 5550(b)(1).

• August 20, 2025, 7:59 PM ET regulatory materiality 0.60 neutral item 8.01

  Inspire Veterinary believes it regained Nasdaq equity compliance via $5M preferred stock sale

  Company received Nasdaq deficiency notice on Apr 10, 2025 for stockholders' equity of $1.56M, below minimum requirement.

• August 4, 2025, 7:59 PM ET other material materiality 0.70 neutral item 1.01item 3.02item 5.03item 9.01 ◈ Governance Changes

  Inspire Veterinary Partners raises up to $10M via Series B convertible preferred stock

  First closing generated ~$5M in cash and transferred securities; up to $4M additional at investor option.

• June 10, 2025, 7:59 PM ET M&A materiality 0.65 positive item 2.01item 3.02item 8.01 ◈ M&A Transactions ×2

  Inspire Veterinary Partners acquires Debary Animal Clinic for ~$2.06M; adds ~$1.8M annual revenue

  Total consideration: $925k for clinic assets ($832.5k cash + 54,734 restricted shares) and $1.132M cash for real estate.

• June 5, 2025, 7:59 PM ET debt materiality 0.60 neutral item 1.01item 3.02

  Inspire Veterinary Partners issues $296,700 of convertible notes at 75% market conversion

  $204,700 note issued to 1800 Diagonal Lending LLC with $24,564 interest, matures March 30, 2026.

• May 13, 2025, 7:59 PM ET leadership materiality 0.20 neutral item 5.02 ◈ executive_change

  Inspire Veterinary appoints CEO Kimball Carr as Chairman of the Board

  Kimball Carr, current CEO, appointed Chairman effective May 1, 2025.

• May 1, 2025, 7:59 PM ET leadership materiality 0.60 positive item 1.01item 3.02item 10.1item 8.01item 7.01

  Inspire promotes Lynley Kees to CPO; YTD DVM hiring up 500%; acquires Debary Animal Clinic for $925K

  Lynley Kees promoted from VP of HR to Chief People Officer, effective April 28, 2025; base salary $235K.

• April 23, 2025, 7:59 PM ET other materiality 0.50 neutral item 1.01item 5.02

  Inspire Veterinary enters CEO agreement with Kimball Carr; base $300k, bonus up to 62.5%

  Base salary of $300,000 per annum; performance bonus of 45% (min) to 62.5% (max) of salary based on KPIs.

• April 11, 2025, 7:59 PM ET regulatory materiality 0.85 negative item 1.01

  Inspire Veterinary Partners receives Nasdaq delisting notice for minimum equity deficiency

  Nasdaq notified Inspire of non-compliance with minimum stockholders' equity requirement; equity reported as $1,562,005.

• March 26, 2025, 7:59 PM ET other material materiality 0.60 neutral item 1.01item 7.01

  Inspire Veterinary raises $2.0M in registered direct offering; warrants could add $4.0M

  Gross proceeds of $2.0M from sale of 1,092,896 shares (or pre-funded warrants) at $1.83/unit.

• March 7, 2025, 6:59 PM ET other material materiality 0.30 neutral item 1.01item 5.02

  Inspire Veterinary enters empl. agreement with CFO Frank; $255K base, bonus up to 50%

  Base salary of $255,000/year; bonus 36%-50% based on revenue, EBITDA, G&A, and M&A KPIs.

• February 13, 2025, 6:59 PM ET other material materiality 0.55 positive item 5.03item 8.01 ◈ Governance Changes

  Inspire Veterinary increases authorized shares to 100M; regains Nasdaq bid price compliance

  Amendment increases authorized Class A common shares to 100M, effective Feb 11, 2025, approved by majority stockholders on Jan 29, 2025.

• January 23, 2025, 6:59 PM ET other material materiality 0.60 negative item 5.03item 7.01item 9.01 ◈ Governance Changes

  Inspire Veterinary Partners to effect 1-for-25 reverse stock split on Jan 27 to meet Nasdaq bid price rule

  Reverse stock split effective Jan 27, 2025 at 1:25 ratio; shares will trade on split-adjusted basis under symbol IVP.

• January 22, 2025, 6:59 PM ET leadership materiality 0.45 neutral item 5.02item 1.01item 9.01

  Inspire Veterinary extends CFO Richard Frank's contract to March 1, 2025

  CFO Richard Frank's employment agreement extended through March 1, 2025; terms unchanged.

• January 10, 2025, 6:59 PM ET other material materiality 0.65 neutral item 3.03item 5.03item 9.01 ◈ Governance Changes

  Inspire Veterinary Partners approves 1-for-25 reverse stock split to regain Nasdaq compliance

  Reverse split effective Jan 3, 2025, converting every 25 shares into 1 share.

• January 2, 2025, 6:59 PM ET other material materiality 0.60 neutral item 1.01item 9.01

  Inspire Veterinary Partners enters $25M ATM stock offering with H.C. Wainwright

  Up to $25M in common stock may be sold at market through H.C. Wainwright as sales agent.

• December 18, 2024, 6:59 PM ET regulatory materiality 0.70 negative item 3.01 ◈ Listing & Compliance Notices

  Inspire Veterinary faces Nasdaq bid price non-compliance; gets public reprimand for prior offering

  Demonstrated compliance with Nasdaq minimum equity rule; subject to Mandatory Panel Monitor until Dec 12, 2025.

• October 23, 2024, 7:59 PM ET other material materiality 0.55 neutral item 1.01item 7.01

  Inspire Veterinary Partners raises $2.5M in registered direct offering of common stock at $0.25/share

  Offering of 10,000,000 shares of Class A common stock at $0.25 per share.

• October 15, 2024, 7:59 PM ET other material materiality 0.75 negative item 1.01item 5.07item 9.01

  Inspire Veterinary Partners cuts warrant exercise price to $0.20 for 2.5M shares

  Reduced exercise price of 2,500,000 warrants from $1.00 to $0.20 effective Oct 8, 2024.

• September 30, 2024, 7:59 PM ET regulatory materiality 0.85 negative item 3.01

  Nasdaq Staff Determines Inspire Veterinary Failed Rule 5635(d); Faces Delisting

  Staff letter dated Sep 24, 2024, says July 15 'best efforts' offering didn't qualify as public offering.

• September 26, 2024, 7:59 PM ET other material materiality 0.55 neutral item 8.01

  Inspire Veterinary sells Kauai clinic to related party for $2.16M; no proceeds

  Sold Kauai Veterinary Clinic in Lihue, HI to Kauai RE Holdings for $2,162,781.

• July 24, 2024, 7:59 PM ET leadership materiality 0.55 neutral item 5.02item 8.01

  CEO Kimball Carr extends contract to Feb 2025; Board forms Steering Committee, Carr relinquishes Chairman role

  CEO Kimball Carr's employment agreement extended through February 1, 2025, effective July 8, 2024.

• July 15, 2024, 7:59 PM ET other material materiality 0.60 neutral item 1.01item 8.01item 9.01

  Inspire Veterinary closes $6M public offering of units with warrants

  Gross proceeds of ~$6M from sale of 6M units at $1.00/unit; each unit includes a share or pre-funded warrant plus a warrant.

• June 10, 2024, 7:59 PM ET regulatory materiality 0.75 negative item 8.01

  Nasdaq grants Inspire Veterinary Partners continued listing until Sept 4, 2024 with conditions

  Company must file registration statement by June 15, 2024 for a public offering led by Spartan Capital Securities.

• April 17, 2024, 7:59 PM ET other material materiality 0.70 negative item 3.03

  Inspire Veterinary Partners approves 100-for-1 reverse stock split to regain Nasdaq compliance

  Board approved 100-for-1 reverse split of common stock; effective upon filing Certificate of Change with Nevada.

• April 15, 2024, 7:59 PM ET regulatory materiality 0.85 negative item 3.01 ◈ Listing & Compliance Notices

  Inspire Veterinary Partners receives Nasdaq delisting notice for negative equity of ($788,259); hearing May 14

  Stockholders' equity of ($788,259) as of Dec 31, 2023 fails Nasdaq listing rule requirements.

• April 4, 2024, 7:59 PM ET debt materiality 0.60 negative item 1.01item 3.02item 5.03item 9.01 ◈ Governance Changes◈ Material Agreements

  Inspire Veterinary issues $500K in senior notes with 15-30% OID; amends Series A preferred floor to $0.01

  Two Increasing OID Senior Notes issued, each $250,000 aggregate principal, total $500,000.

• March 12, 2024, 7:59 PM ET other material materiality 0.30 neutral item 1.01item 3.02

  Inspire Veterinary issues ~2.1M restricted shares for consulting and prior acquisition settlement

  Issued 1,865,875 shares ($151,695.60) to Dr. Charles Keiser for consulting services under a Consulting Agreement.

• March 12, 2024, 7:59 PM ET regulatory materiality 0.90 negative item 3.01 ◈ Listing & Compliance Notices

  Inspire Veterinary receives Nasdaq delisting notice; stock bid price $0.10 or less for 10 days

  On March 8, 2024, Nasdaq issued a Staff Determination to delist IVP because closing bid price was $0.10 or less for 10+ consecutive trading days.

• February 16, 2024, 6:59 PM ET leadership materiality 0.50 neutral item 1.01item 5.02

  Inspire Veterinary Partners formalizes CFO Richard Frank's employment agreement with $210K base salary

  Employment agreement effective Jan 1, 2024; initial term of 1 year, renewable by board vote.

• February 14, 2024, 6:59 PM ET other material materiality 0.40 neutral item 3.02

  Inspire Veterinary issues 1.2M shares and warrant to Tumim Stone Capital as commitment shares

  Issued 1,214,293 Class A common shares to Tumim on Feb 14, 2024.

• February 13, 2024, 6:59 PM ET other material materiality 0.60 neutral item 8.01

  Inspire Veterinary closes $4.0M public offering of common stock and warrants

  Gross proceeds of ~$4.0M from 47,058,823 shares/pre-funded warrants at $0.085 each.

• February 9, 2024, 6:59 PM ET other material materiality 0.65 negative item 1.01item 8.01 ◈ Material Agreements ×2

  Inspire Veterinary Partners prices $4.0M public offering at $0.085/share; enters consulting deals totaling $2M

  Public offering of up to $4.0M gross proceeds priced at $0.085/share; includes 47.1M common shares and pre-funded warrants.

• January 8, 2024, 6:59 PM ET other material materiality 0.35 neutral item 1.01item 3.02 ◈ Material Agreements

  Inspire Veterinary raises $200K via private placement of Series A preferred

  Sold 20,000 shares of Series A preferred stock to Target Capital 1, LLC for gross proceeds of $200,000.

• January 4, 2024, 6:59 PM ET other material materiality 0.60 neutral item 1.01item 3.02 ◈ Material Agreements

  Inspire amends Tumim Stone financing agreement; adds ownership caps, warrant conversion, cash alternative

  New cap limits Tumim Stone beneficial ownership to 4.99%; excess converted to warrant at $0.0001/share.

• December 6, 2023, 6:59 PM ET other material materiality 0.55 neutral item 1.01item 3.02 ◈ Material Agreements

  Inspire enters $30M common stock purchase agreement with Tumim Stone Capital

  Up to $30M aggregate gross purchase price; shares sold at 95% of lowest VWAP over 3 days following purchase notice.

Executive changes

Materiality & sentiment trend

Max materiality 0.90 · Median 0.60 · Most common event other_material

4 positive 19 negative 27 neutral

source · IVPR on sec.gov